Table 1.
Formulation composition and obtained responses of 15 different formulation obtained from Box–Behnken design. X1 = amount of lipid, X2 = amount of surfactant, X3 = amount of drug, Y1 = particle size, Y2 = PDI, Y3 = zeta potential, Y4 = AE and Y5 = DL.
independent variables |
dependent variables |
|||||||
---|---|---|---|---|---|---|---|---|
formulation | X1 (mg) | X2 (mg) | X3 (mg) | Y1 (nm) | Y2 | Y3 (mV) | Y4 (%) | Y5 (%) |
F1 | 250 | 60 | 7 | 208.0 | 0.127 | −28.04 | 67.8 | 1.88 |
F2 | 350 | 60 | 7 | 236.5 | 0.158 | −32.31 | 61.9 | 1.26 |
F3 | 250 | 100 | 7 | 169.0 | 0.174 | −23.17 | 67.0 | 1.85 |
F4 | 350 | 100 | 7 | 195.0 | 0.158 | −23.62 | 62.4 | 1.57 |
F5 | 250 | 80 | 4 | 198.1 | 0.164 | −30.88 | 70.8 | 1.10 |
F6 | 350 | 80 | 4 | 227.1 | 0.169 | −29.08 | 83.0 | 0.94 |
F7 | 250 | 80 | 10 | 204.3 | 0.165 | −25.73 | 62.4 | 2.26 |
F8 | 350 | 80 | 10 | 221.2 | 0.156 | −21.78 | 81.7 | 2.02 |
F9 | 300 | 60 | 4 | 203.3 | 0.193 | −27.18 | 62.7 | 0.81 |
F10 | 300 | 100 | 4 | 187.0 | 0.168 | −38.28 | 77.4 | 0.97 |
F11 | 300 | 60 | 10 | 220.7 | 0.154 | −29.61 | 75.0 | 2.39 |
F12 | 300 | 100 | 10 | 177.5 | 0.154 | −24.65 | 69.5 | 2.24 |
F13 | 300 | 80 | 7 | 227.2 | 0.155 | −32.09 | 71.2 | 1.63 |
F14 | 300 | 80 | 7 | 219.7 | 0.194 | −29.93 | 80.6 | 1.87 |
F15 | 300 | 80 | 7 | 219.7 | 0.147 | −28.52 | 74.7 | 1.61 |